Effects of Tenofovir Disoproxil Fumarate in Hepatitis B e Antigen-Positive Patients With Normal Levels of Alanine Aminotransferase and High Levels of Hepatitis B Virus DNA - Chan, Henry L.Y.; Chan, Chi Kuen; Hui, Aric Josun; Chan, Sing; Poordad, Fred; Chang, Ting-Tsung; Mathurin, Philippe; Flaherty, John F.; Lin, Lanjia; Corsa, Amy; Gaggar, Anuj; Subramanian, G. Mani; et al. (Gastroenterology (New York, N.Y. 1943), 2014)
Keywords: Adenine - adverse effects; Adenine - analogs & derivatives; Adenine - therapeutic use; Adolescent; Adult; Alanine Transaminase - blood; Antiviral Agents - adverse effects; Antiviral Agents - therapeutic use; Biomarkers - blood; Combination Therapy; Deoxycytidine - analogs & derivatives; Deoxycytidine - therapeutic use; DNA, Viral - blood; Double-Blind Method; Drug Therapy, Combination; Emtricitabine; Female; FTC; Gastroenterology and Hepatology; HBsAg; Hepatitis B e Antigens - blood; Hepatitis B virus - drug effects; Hepatitis B virus - genetics; Hepatitis B virus - immunology; Hepatitis B, Chronic - blood; Hepatitis B, Chronic - diagnosis; Hepatitis B, Chronic - drug therapy; Humans; Immune Tolerance; Immune Tolerant; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Phosphorous Acids - adverse effects; Phosphorous Acids - therapeutic use; Time Factors; Treatment Outcome; Viral Load; Young Adult; FTC; Combination Therapy; ULN; HBeAg; TDF; pol/RT; HBsAg; ALT; HCC; Immune Tolerant; CHB; HBV; chronic hepatitis B; emtricitabine; hepatitis B surface antigen; hepatitis B virus; alanine aminotransferase; hepatitis B e antigen; upper limit of normal; tenofovir disoproxyl fumarate; polymerase/reverse transcriptase; hepatocellular carcinoma